| Direct Competitor Comparison | |
|---|
| RGEN | BIO | PVT1 | LIFE | Industry |
|---|
| Market Cap: | 261.44M | 3.31B | N/A | 12.74B | 71.76B |
|---|
| Employees: | 120 | 7,380 | 1,1001 | 10,000 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.28 | 0.03 | N/A | 0.03 | 0.27 |
|---|
| Revenue (ttm):
| 65.90M | 2.08B | 131.00M1 | 3.82B | 13.93B |
|---|
| Gross Margin (ttm): | 0.56 | 0.55 | N/A | 0.65 | 0.72 |
|---|
| EBITDA (ttm): | 17.77M | 352.88M | N/A | 1.20B | 1.51B |
|---|
| Operating Margin (ttm):
| 0.22 | 0.11 | N/A | 0.21 | 0.13 |
|---|
| Net Income (ttm): | 15.27M | 152.27M | -381.10M1 | 419.41M | N/A |
|---|
| EPS (ttm): | 0.48 | 5.31 | N/A | 2.36 | 0.61 |
|---|
| P/E (ttm): | 17.22 | 21.87 | N/A | 31.32 | 18.43 |
|---|
| PEG (5 yr expected): | N/A | 2.28 | N/A | 1.75 | 1.51 |
|---|
| P/S (ttm): | 3.93 | 1.58 | N/A | 3.34 | 3.64 |
|---|
|
| BIO = Bio-Rad Laboratories, Inc. | | Pvt1 = Human Genome Sciences, Inc. (privately held) | | LIFE = Life Technologies Corporation | | Industry = Biotechnology | | 1 = As of 2011 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 104.45 | -0.00 | 78.93B | 17.68 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 229.31 | -0.02 | 55.00B | 36.39 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.11 | -0.01 | 85.02B | 30.86 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.97 | -0.00 | 12.74B | 31.32 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.14 | -0.01 | 33.44B | 19.54 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 129.21 | -0.01 | 16.54B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.49 | -0.00 | 12.00B | 21.04 |
|---|
| Pfizer Inc. | PFE | 29.03 | -0.01 | 206.63B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 87.37 | -0.00 | 245.32B | 23.73 |
|---|
| GlaxoSmithKline plc | GSK | 52.38 | -0.01 | 127.13B | 19.14 |
|---|
| Sanofi | SNY | 54.58 | -0.01 | 144.91B | 26.90 |
|---|
| Novartis AG | NVS | 74.12 | -0.01 | 181.88B | 18.81 |
|---|
| Roche Holding AG | RHHBY | 64.66 | -0.02 | 219.45B | 21.64 |
|---|
| AstraZeneca PLC | AZN | 51.68 | -0.01 | 64.65B | 11.43 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.59 | -0.00 | 58.54B | 11.46 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.32 | -0.00 | 76.36B | 52.46 |
|---|
|
| News on Direct Competitors | |
|---|
- LIFE
- Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic Analyzers in Canada CNW Group Mon, May 20
- BIO
- BIO RAD LABORATORIES INC Financials EDGAR Online Financials Fri, May 17
- LIFE
- Today’s Research on LIFE, OPK, BKD, MDCO, and DVA Accesswire Thu, May 16
- BIO
- Danaher Proves Even The Nimble Can Stumble at Investopedia Tue, May 14
- LIFE
- American CryoStem Partners with Rutgers for Novel Wound Care Product Accesswire Tue, May 14
- BIO
- Bio-Rad Named One of the 'Best Places to Work 2013' in the San Francisco Bay Area Marketwired Mon, May 13
- BIO
- 5 Healthcare Stock Earnings Snapshots at Wall St. Cheat Sheet Sun, May 12
- BIO
- BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online Fri, May 10
- LIFE
- Bidders for Carestream down to Bain, THL: sources Reuters Thu, Apr 25
- LIFE
- Life Technologies' Ion Proton™ to Power Stratified Medicine Scotland Innovation Centre CNW Group Tue, Apr 23
All headlines for these symbols... Currency in USD. | |
|
0.09(1.03%) 10:25AM EDT - Nasdaq Real Time Price